Contact
searchSearch
HMP Global

Chronic Graft vs Host Disease

News
Pomalidomide May Improve Motor and Function in Steroid-Refractory cGVHD
06/13/2025
Grace Taylor, MS, MA
Pomalidomide may enhance motor performance and quality of life in patients with steroid-refractory chronic graft-versus-host disease, according to a study published in Transplantation and Cellular Therapy.
Pomalidomide may enhance motor performance and quality of life in patients with steroid-refractory chronic graft-versus-host disease, according to a study published in Transplantation and Cellular Therapy.
Pomalidomide may enhance motor...
06/13/2025
First Report Managed Care
News
Belumosudil Combinations Show Promise in Steroid-Refractory cGVHD, Especially With Ruxolitinib
05/22/2025
Lisa Kuhns, PhD, MD
Combining belumosudil (BEL) with ruxolitinib (RUX) may offer improved clinical benefit for patients with steroid-refractory chronic graft-versus-host disease (SR-cGVHD) compared to standard combination therapies, according to an observational...
Combining belumosudil (BEL) with ruxolitinib (RUX) may offer improved clinical benefit for patients with steroid-refractory chronic graft-versus-host disease (SR-cGVHD) compared to standard combination therapies, according to an observational...
Combining belumosudil (BEL) with...
05/22/2025
First Report Managed Care
News
Extracorporeal Photopheresis Shows Promising Efficacy in Steroid-Refractory cGvHD
05/15/2025
Lisa Kuhns, PhD, MD
Extracorporeal photopheresis (ECP) is a safe and effective second-line treatment option for patients with steroid-refractory chronic graft-versus-host disease (SR-cGvHD), with sustained survival benefits and clinically meaningful response...
Extracorporeal photopheresis (ECP) is a safe and effective second-line treatment option for patients with steroid-refractory chronic graft-versus-host disease (SR-cGvHD), with sustained survival benefits and clinically meaningful response...
Extracorporeal photopheresis...
05/15/2025
First Report Managed Care
News
Body Composition Analysis Predicts Survival in Patients With Cancer and cGVHD
04/29/2025
Grace Taylor, MS, MA
CT-based body composition analysis can help predict mortality risk in patients with cancer who have chronic graft vs host disease following stem cell transplant, according to a study published in the Journal of Cachexia, Sarcopenia and Muscle.
CT-based body composition analysis can help predict mortality risk in patients with cancer who have chronic graft vs host disease following stem cell transplant, according to a study published in the Journal of Cachexia, Sarcopenia and Muscle.
CT-based body composition...
04/29/2025
First Report Managed Care
Headshot of Meilin Diaz-Paez, University of Miami, on a blue background underneath the PopHealth Perspectives logo.
Videos
Improving Patient Access to Therapies for Chronic Graft vs Host Disease
09/01/2022
Maria Asimopoulos
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, describes what payers should know about patients...
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, describes what payers should know about patients...
Meilin Diaz-Paez, MSN, APRN,...
09/01/2022
First Report Managed Care
Meilin_Diaz_Paez_University_Miami
Videos
Treatment Options for Patients With Chronic Graft vs Host Disease
09/01/2022
Maria Asimopoulos
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, walks through available therapies for patients...
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, walks through available therapies for patients...
Meilin Diaz-Paez, MSN, APRN,...
09/01/2022
First Report Managed Care
Headshot of Meilin Diaz-Paez, University of Miami, on a blue background underneath the PopHealth Perspectives logo.
Videos
Understanding Symptom Burden, Disease Severity in Graft vs Host Disease
09/01/2022
Maria Asimopoulos
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, reviews the symptom burden associated with...
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, reviews the symptom burden associated with...
Meilin Diaz-Paez, MSN, APRN,...
09/01/2022
First Report Managed Care
Industry Insights
News
Expert Perspectives
Videos

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use